Shravan Morla

Title: Innovations in Cancer Treatment by Shravan Morla

Introduction

Shravan Morla is an accomplished inventor based in Richmond, VA (US). He has made significant contributions to the field of cancer research, particularly through his innovative work on anti-cancer agents. His research focuses on developing compounds that selectively target cancer stem cells, which are known to contribute to cancer recurrence and resistance to treatment.

Latest Patents

Shravan Morla holds a patent for "Lipidic analogs of anti-cancer stem cell agent." This patent describes a group of specific sulfated flavonoid agents that carry cholesterol modifications. These agents display promising in vivo anti-cancer activity by selectively inhibiting cancer stem cells while sparing adult or hematopoietic stem cells. The compounds exhibit high potency, excellent oral bioavailability, and a physiologically relevant therapeutic window. He has 1 patent to his name.

Career Highlights

Shravan Morla is affiliated with Virginia Commonwealth University, where he conducts his research. His work has garnered attention for its potential to revolutionize cancer treatment by targeting the root causes of cancer rather than just the symptoms. His innovative approach has positioned him as a key figure in the ongoing battle against cancer.

Collaborations

Some of his notable coworkers include Umesh R Desai and Balaji Nagarajan. Their collaborative efforts contribute to the advancement of research in cancer therapies and the development of new treatment modalities.

Conclusion

Shravan Morla's innovative work in developing lipidic analogs of anti-cancer agents highlights the importance of targeted therapies in cancer treatment. His contributions to the field are paving the way for more effective and selective cancer treatments.